Contact us AND COMPLAINTS

If you have any enquiries regarding your Goldman Sachs & JBWere Superannuation Fund account there are various ways to contact us for help and assistance. For additional information about the Fund and its key features, you should also refer to the Product Disclosure Statement relevant to your section of the Fund available from the Documents & Forms section of this site.

Call us: 1800 025 026

Fax us: +61 3 9245 5827

Email us: GSJBWAdmin@mercer.com

Write to us: The Goldman Sachs & JBWere Superannuation Fund, GPO Box 4303, Melbourne VIC 3001

Overseas: +61 3 8687 1861

You can reach us between 8.30am and 7.00pm AEST/AEDT, Monday to Friday, except for national public holidays. To contact the Fund’s Privacy Officer or Complaints Officer, please write to the appropriate officer at the above address.

External Dispute Resolution

If you have already made a complaint to us and you are not satisfied with the response provided to you, or after 45 days has passed since you first complained, then you have the option to refer your complaint to the Australian Financial Complaints Authority (AFCA). AFCA can be contacted at:

Online: www.afca.org.au

Email: info@afca.org.au

Phone: 1800 931 678

Mail: Australian Financial Complaints Authority, GPO Box 3 Melbourne, Victoria, 3001

AFCA replaced the Superannuation Complaints Tribunal (SCT) as the relevant external dispute resolution body for complaints about superannuation from 1 November 2018. For more details about referring a complaint to AFCA, how AFCA handle complaints, and time limits that may apply contact AFCA directly.

The information contained on this website is not updated in real time, so figures may be subject to change from time to time. This content is current as at March 2024.
BEST Superannuation Pty Ltd ABN 57 070 732 008, AFS Licence No. 530672, RSE Licence No. L0001939 is the trustee of the Goldman Sachs & JBWere Superannuation Fund ABN 55 697 537 183, RSE registration #R1005271. You should consider the Product Disclosure Statements for the Fund (available here) and the Target Market Determinations (available here) before making any decisions in relation to this product.